Related Experiment Videos
Recurrence of cranial base meningiomas
T Mathiesen1, C Lindquist, L Kihlström
1Department of Neurosurgery, Karolinska Hospital, Stockholm, Sweden.
Neurosurgery
|July 1, 1996
Summary
Long-term follow-up of cranial base meningiomas treated traditionally shows that nonradical surgery is often a temporary measure. Careful, long-term patient monitoring is essential for evaluating treatment and detecting recurrences.
Area of Science:
- Neurosurgery
- Oncology
- Pathology
Background:
- Long-term data on traditionally treated cranial base meningiomas are crucial for assessing modern surgical techniques.
- Understanding the natural history of these tumors informs decisions regarding nonradical surgical approaches.
Purpose of the Study:
- To evaluate the long-term outcomes of cranial base meningiomas treated before the era of advanced surgical techniques.
- To provide data for comparing traditional treatments with modern cranial base surgery.
- To determine the long-term efficacy and necessity of nonradical surgical interventions.
Main Methods:
- Retrospective review of 315 patients operated on between 1947 and 1982.
- Analysis of perioperative mortality, 10-year mortality, and long-term follow-up (10-36 years).
- Assessment of recurrence rates and symptomatic progression based on surgical grades (1-5).
Main Results:
- 5-year recurrence rates varied from 4% (radical surgery) to 25-45% (nonradical surgery).
- Long-term follow-up revealed symptomatic recurrences in 16-20% of Grade 1-2 patients and progression in most Grade 4-5 patients.
- Tumor progression or recurrence typically occurred within 10 years, but late recurrences were observed up to 25 years; medial sphenoid wing/clinoidal and cavernous sinus-invading tumors had the worst outcomes.
Conclusions:
- Management of cranial base meningiomas requires a 10- to 20-year perspective.
- Continuous patient follow-up is necessary to evaluate treatment effectiveness and detect recurrences.
- Nonradical surgery should be considered palliative; further research into radical treatment options is warranted for these challenging tumors.